These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25972369)

  • 1. Comparative study of CT appearances in renal oncocytoma and chromophobe renal cell carcinoma.
    Wu J; Zhu Q; Zhu W; Chen W; Wang S
    Acta Radiol; 2016 Apr; 57(4):500-6. PubMed ID: 25972369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential diagnosis of renal oncocytoma and chromophobe renal cell carcinoma using CT features: a central scar-matched retrospective study.
    Li X; Nie P; Zhang J; Hou F; Ma Q; Cui J
    Acta Radiol; 2022 Feb; 63(2):253-260. PubMed ID: 33497276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of computed tomography findings between renal oncocytomas and chromophobe renal cell carcinomas.
    Choi JH; Kim JW; Lee JY; Han WK; Rha KH; Choi YD; Hong SJ; Yoon YE
    Korean J Urol; 2015 Oct; 56(10):695-702. PubMed ID: 26495070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segmental enhancement inversion at biphasic multidetector CT: characteristic finding of small renal oncocytoma.
    Kim JI; Cho JY; Moon KC; Lee HJ; Kim SH
    Radiology; 2009 Aug; 252(2):441-8. PubMed ID: 19508984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CT-based radiomics nomogram for differentiation of renal oncocytoma and chromophobe renal cell carcinoma with a central scar-matched study.
    Li X; Ma Q; Nie P; Zheng Y; Dong C; Xu W
    Br J Radiol; 2022 Jan; 95(1129):20210534. PubMed ID: 34735296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.
    Conner JR; Hirsch MS; Jo VY
    Cancer Cytopathol; 2015 May; 123(5):298-305. PubMed ID: 25739652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of segmental enhancement inversion on biphasic MDCT between small renal oncocytomas and chromophobe renal cell carcinomas.
    Woo S; Cho JY; Kim SH; Kim SY
    AJR Am J Roentgenol; 2013 Sep; 201(3):598-604. PubMed ID: 23971452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of renal oncocytoma and renal clear cell carcinoma using relative CT enhancement ratio.
    Ren A; Cai F; Shang YN; Ma ES; Huang ZG; Wang W; Lu Y; Zhang XZ
    Chin Med J (Engl); 2015 Jan; 128(2):175-9. PubMed ID: 25591558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic utility of amylase α-1A, MOC 31, and
    Abouhashem NS; Abdelbary EH; H Abdalla MM; El-Shazly M
    Indian J Pathol Microbiol; 2020; 63(3):405-411. PubMed ID: 32769329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.
    Dhyani M; Grajo JR; Rodriguez D; Chen Z; Feldman A; Tambouret R; Gervais DA; Arellano RS; Hahn PF; Samir AE
    Abdom Radiol (NY); 2017 Jun; 42(6):1734-1743. PubMed ID: 28197683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses.
    Lee-Felker SA; Felker ER; Tan N; Margolis DJ; Young JR; Sayre J; Raman SS
    AJR Am J Roentgenol; 2014 Nov; 203(5):W516-24. PubMed ID: 25341166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
    Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
    Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.
    Liu Q; Cornejo KM; Cheng L; Hutchinson L; Wang M; Zhang S; Tomaszewicz K; Cosar EF; Woda BA; Jiang Z
    Am J Pathol; 2018 Apr; 188(4):846-852. PubMed ID: 29353061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of conventional diffusion-weighted imaging and intravoxel incoherent motion in differentiating between chromophobe renal cell carcinoma and renal oncocytoma: a preliminary study.
    Zhu Q; Sun J; Ye J; Zhu W; Chen W
    Br J Radiol; 2024 May; 97(1158):1146-1152. PubMed ID: 38688580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma.
    An J; Park CK; Kim M; Joo JW; Cho NH
    Virchows Arch; 2021 Mar; 478(3):459-470. PubMed ID: 32816058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation between renal oncocytomas and chromophobe renal cell carcinomas using dynamic contrast-enhanced computed tomography.
    Guo K; Ren S; Cao Y; Zhang H; Zhang Y; Gu X; Wang Z
    Abdom Radiol (NY); 2021 Jul; 46(7):3309-3316. PubMed ID: 33710383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
    Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC
    Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.
    Mai KT; Teo I; Belanger EC; Robertson SJ; Marginean EC; Islam S
    Histopathology; 2008 Feb; 52(3):277-82. PubMed ID: 18081814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.